SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-008294
Filing Date
2018-04-17
Accepted
2018-04-17 08:31:01
Documents
5
Period of Report
2018-04-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20180417.htm 8-K 33235
2 EX-99.1 life-ex991_61.htm EX-99.1 15937
3 EX-99.2 life-ex992_76.htm EX-99.2 16702
4 GRAPHIC gsepzdmifqt3000001.jpg GRAPHIC 4163276
5 GRAPHIC gretec3jf4lr000001.jpg GRAPHIC 3655712
  Complete submission text file 0001564590-18-008294.txt   10834625
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 18757926
SIC: 2836 Biological Products, (No Diagnostic Substances)